Compare LTGO & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LTGO | DEA |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2026 | 2014 |
| Metric | LTGO | DEA |
|---|---|---|
| Price | $21.97 | $24.43 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.49 |
| AVG Volume (30 Days) | 292.6K | ★ 309.2K |
| Earning Date | N/A | 04-27-2026 |
| Dividend Yield | N/A | ★ 7.77% |
| EPS Growth | N/A | ★ 50.00 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $336,099,000.00 |
| Revenue This Year | N/A | $5.41 |
| Revenue Next Year | N/A | $3.33 |
| P/E Ratio | ★ N/A | $306.13 |
| Revenue Growth | N/A | ★ 11.27 |
| 52 Week Low | $17.22 | $20.56 |
| 52 Week High | $25.93 | $25.96 |
| Indicator | LTGO | DEA |
|---|---|---|
| Relative Strength Index (RSI) | 61.32 | 45.08 |
| Support Level | $18.46 | $24.30 |
| Resistance Level | $25.47 | $25.12 |
| Average True Range (ATR) | 1.87 | 0.42 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 46.72 | 21.89 |
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.